Publicaciones en las que colabora con José Antonio López Guerrero (77)

2024

  1. The Combined Immunohistochemical Expression of GLI1 and BCOR in Synovial Sarcomas for the Identification of Three Risk Groups and Their Prognostic Outcomes: A Study of 52 Patients

    International Journal of Molecular Sciences, Vol. 25, Núm. 14

  2. The value of GLI1 and p16 immunohistochemistry in the premolecular screening for GLI1-altered mesenchymal neoplasms

    Virchows Archiv, Vol. 484, Núm. 5, pp. 765-775

2023

  1. Adult Pancreatoblastoma: Report of 3 new Cases With Genetic Diversity and Autopsy Findings

    International Journal of Surgical Pathology, Vol. 31, Núm. 5, pp. 896-906

  2. Extra-meningeal solitary fibrous tumor: an evolving entity with chameleonic morphological diversity, a hallmark molecular alteration and unresolved issues in risk stratification assessment

    Histology and histopathology, Vol. 38, Núm. 10, pp. 1079-1097

  3. Extraskeletal myxoid chondrosarcoma: p53 and Ki-67 offer prognostic value for clinical outcome — an immunohistochemical and molecular analysis of 31 cases

    Virchows Archiv, Vol. 482, Núm. 2, pp. 407-417

  4. Intimal Sarcoma with MDM2/CDK4 Amplification and p16 Overexpression: A Review of Histological Features in Primary Tumor and Xenograft, with Immunophenotype and Molecular Profiling

    International Journal of Molecular Sciences, Vol. 24, Núm. 8

  5. Tumor Microenvironment and Its Clinicopathologic and Prognostic Association in Cutaneous and Noncutaneous Angiosarcomas

    American journal of clinical pathology, Vol. 160, Núm. 1, pp. 18-34

2022

  1. Does PAX7 and NKX2.2 immunoreactivity in Ewing sarcoma have prognostic significance?

    Virchows Archiv, Vol. 480, Núm. 4, pp. 909-917

2021

  1. Angiosarcomas: Histology, immunohistochemistry and molecular insights with implications for differential diagnosis

    Histology and Histopathology, Vol. 36, Núm. 1, pp. 3-18

  2. Neuroendocrine differentiation in a large series of genetically-confirmed Ewing's sarcoma family tumor: Does it provide any diagnostic or prognostic information?

    Pathology Research and Practice, Vol. 219

2020

  1. Prognostic impact of let-7e microRNA and its target genes in localized high-risk intestinal GIST: A spanish group for research on sarcoma (GEIS) study

    Cancers, Vol. 12, Núm. 10, pp. 1-18

  2. The Frequency and Prognostic Significance of the Histologic Type in Early-stage Ovarian Carcinoma: A Reclassification Study by the Spanish Group for Ovarian Cancer Research (GEICO)

    American Journal of Surgical Pathology, Vol. 44, Núm. 2, pp. 149-161

2019

  1. Chemokine Expression Is Involved in the Vascular Neogenesis of Ewing Sarcoma: A Preliminary Analysis of the Early Stages of Angiogenesis in a Xenograft Model

    Pediatric and Developmental Pathology, Vol. 22, Núm. 1, pp. 30-39

2017

  1. Expression profiles of angiogenesis in two high grade chondrosarcomas: A xenotransplant experience in nude mice

    Histology and Histopathology, Vol. 32, Núm. 12, pp. 1281-1291

  2. High-risk gastrointestinal stromal tumour (GIST) and synovial sarcoma display similar angiogenic profiles: A nude mice xenograft study

    ecancermedicalscience, Vol. 11

  3. Immunohistochemical analysis of NKX2.2, ETV4, and BCOR in a large series of genetically confirmed Ewing sarcoma family of tumors

    Pathology Research and Practice, Vol. 213, Núm. 9, pp. 1048-1053

2015

  1. Biphasic dermatofibrosarcoma protuberans with a labyrinthine plexiform high-grade fibrosarcomatous transformation

    Journal of Cutaneous Pathology

  2. RG7112, a Small-Molecule Inhibitor of MDM2, Enhances Trabectedin Response in Soft Tissue Sarcomas

    Cancer Investigation, Vol. 33, Núm. 9, pp. 440-450

  3. The early stages of tumor angiogenesis in human osteosarcoma: a nude mice xenotransplant model

    Virchows Archiv, Vol. 467, Núm. 2, pp. 193-201

2014

  1. MRP1 overexpression determines poor prognosis in prospectively treated patients with localized high-risk soft tissue sarcoma of limbs and trunk wall: An ISG/GEIS study

    Molecular Cancer Therapeutics, Vol. 13, Núm. 1, pp. 249-259